A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients

NCT03973112 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: HLX10 3mg/kg
DRUG: HLX04 5mg/kg
DRUG: HLX04 10mg/kg

Sponsor

Shanghai Henlius Biotech